Leprosy
Why in News:
- Clofazimine, a key drug for treatment of leprosy, has been in short supply in the Indian market.
About
- Hansen’s disease (also known as leprosy) is a chronic, progressive infection caused by slow-growing bacteria called Mycobacterium leprae.
- It can affect the nerves, skin, eyes, and lining of the nose (nasal mucosa). With early diagnosis and treatment, the disease can be cured.
- Symptoms often take between three and five years to manifest.
- Hansen’s disease is treated with a combination of antibiotics. Typically, 2 or 3 antibiotics are used at the same time. The combination of medications known as “Multi-Drug Therapy” can cure leprosy (MDT).
- Leprosy has been recorded as one of the oldest illness. Leprosy has been documented in writing as early as 600 B.C.
- Thousands of years ago, it was fully understood by the first civilisations in China, Egypt, and India. The existence of leprosy infections in 100,000-year-old remains is supported by genetic data.
- The main method of transmission is inhaling airborne droplets from the infected people. The disease can be contracted at any age
Leprosy in India
- According to the World Health Organization (WHO), leprosy is endemic in several States and Union Territories of India, with the annual case detection rate of 4.56 per 10,000 population.
- The prevalence rate of leprosy is 0.4 per 10,000 population in the country. Of the new cases detected during 2020-2021, 58.1% were multibacillary, 39% were women, 5.8% were children less than 14 years of age, and 2.41% had visible deformities.
- The rate of visible deformities was 1.1 per million population
Initiatives
- National Leprosy Control Programme in 1955
- The World Bank supported National Leprosy Elimination Project started from 1993-94.
- The National Health Policy 2002, Government of India had set the goal of elimination of leprosy i.e. to reduce the no. of cases to < 1/10,000 population by the year 2005.
- The National Leprosy Eradication Programme – achieved the goal of elimination of leprosy as a public health problem, defined as less than 1 case per 10,000 Population, at the National Level in 2005.
- SPARSH Leprosy Awareness Campaign – to promote awareness and address the issues of stigma and discrimination.
- World Health Organisation- Global Leprosy strategy document for 2016–2020 – promoting inter-sectoral collaboration within countries.
Reference
Subscribe
Login
0 Comments